Alkanesulfonamides as antiglaucoma agents

Details Alkanesulfonamides as antiglaucoma agents Alkanesulfonamides as antiglaucoma agents

1987-12-10

1989-03-14

Sutto, Anton H.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514357, 514400, 514445, 546136, 546338, 548342, 549 65, 564 84, 564 89, 564 98, A61K 3147, A61K 3164, C07C14372, C07C43302

Patent

active

048124630

ABSTRACT:
Alkane sulfonamides with an electron withdrawing function .beta. to the sulfonamide group are topically effective carbonic anhydrase inhibitors useful in the treatment of elevated intraocular pressure and glaucoma.

REFERENCES:
patent: 3501578 (1970-03-01), Schlor et al.
patent: 3862184 (1975-01-01), Goralski et al.
patent: 3862935 (1975-01-01), Goralski
patent: 3865822 (1975-02-01), Goralski et al.
patent: 3895010 (1975-07-01), Goralski et al.
patent: 3946007 (1976-03-01), Goralski et al.
patent: 4628109 (1986-12-01), Schmidt et al.
patent: 4650902 (1987-03-01), Bender et al.
patent: 4691056 (1987-09-01), Gunther
patent: 4721794 (1988-01-01), Shepard et al.

Affiliated with

Also associated with

Rating

Alkanesulfonamides as antiglaucoma agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Alkanesulfonamides as antiglaucoma agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkanesulfonamides as antiglaucoma agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-893954